Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2-Syria, 2017-2018

被引：22

作者：

Mbaeyi, Chukwuma ^{[1
]}

Wadood, Zubair Mufti ^{[2
]}

Moran, Thomas ^{[2
]}

Ather, Fazal ^{[3
]}

Stehling-Ariza, Tasha ^{[4
]}

Nikulin, Joanna ^{[2
]}

Al Safadi, Mohammad ^{[2
]}

Iber, Jane ^{[5
]}

Zomahoun, Laurel ^{[1
]}

Abourshaid, Nidal ^{[6
]}

Pang, Hong ^{[5
]}

Collins, Nikki ^{[5
]}

Asghar, Humayun ^{[2
]}

Butt, Obaid ul Islam ^{[2
]}

Burns, Cara C. ^{[5
]}

Ehrhardt, Derek ^{[1
]}

Sharaf, Magdi ^{[2
]}

机构：

[1] CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA 30333 USA

[2] WHO, Polio Eradicat Dept, Geneva, Switzerland

[3] United Nations Childrens Fund, Middle East & North Africa Off, Amman, Jordan

[4] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA

[5] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA

[6] United Nations Childrens Fund, Syria Country Off, Damascus, Syria

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2018年 / 67卷 / 24期

关键词：

PROGRESS; ERADICATION; WORLDWIDE;

D O I：

10.15585/mmwr.mm6724a5

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

What is already known about this topic? Oral poliovirus vaccine (OPV) contains live attenuated viruses, which rarely revert to neurovirulence. These vaccine-derived polioviruses (VDPVs) tend to emerge in populations with low OPV coverage and are capable of causing paralysis. What is added by this report? In 2017, an outbreak of circulating VDPV type 2 (cVDPV2) occurred in Syria, causing 74 cases. Implementation of three rounds of monovalent OPV type 2 campaigns coupled with intensified surveillance interrupted the outbreak. What are the implications for public health practice? The outbreak in Syria underscores the risk for emergence of vaccine-derived polioviruses in settings of low OPV coverage. High-quality surveillance and targeted vaccination using monovalent OPV type 2 are effective in controlling cVDPV2 outbreaks. © 2018, Department of Health and Human Services. All Rights reserved.

引用

页码：690 / 694

页数：5

共 50 条

[1] Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response - Papua New Guinea, 2018
Bauri, Mathias
Wilkinson, Amanda L.
Ropa, Berry
Feldon, Keith
Snider, Cynthia J.
Anand, Abhijeet
Tallis, Graham
Boualam, Liliane
Grabovac, Varja
Avagyan, Tigran
Reza, Mohammad S.
Mekonnen, Dessie
Zhang, Zaixing
Thorley, Bruce R.
Shimizu, Hiroyuki
Apostol, Lea Necitas G.
Takashima, Yoshihiro
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (05): : 119 - 120
[2] Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response - Horn of Africa, 2017-2018
Eboh, Victor A.
Makam, Jeevan K.
Chitale, Rohit A.
Mbaeyi, Chukwuma
Jorba, Jaume
Ehrhardt, Derek
Durry, Elias
Gardner, Tracie
Mohamed, Kamil
Kamugisha, Christopher
Borus, Peter
Elsayed, Eltayeb Ahmed
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (28): : 787 - 789
[3] Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak-Tajikistan
O'Connor, Patrick
Huseynov, Shahin
Nielsen, Carrie F.
Saidzoda, Faizali
Saxentoff, Eugene
Sadykova, Umeda
Kormoss, Patricia
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (09): : 361 - 362
[4] A closer look at Indonesia's circulating vaccine-derived poliovirus type 2 outbreak
Satapathy, Prakasini
Kumar, Pawan
Sharma, Ayush
Rustagi, Sarvesh
Gaidhane, Shilpa
Zahiruddin, Quazi Syed
Mehta, Rachana
Sah, Sanjit
Harapan, Harapan
JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (08)
[5] OUTBREAK OF ENVIRONMENTALLY ISOLATED TYPE 2 CIRCULATING VACCINE-DERIVED POLIOVIRUS IN METROPOLITAN KANO, NORTHWESTERN NIGERIA. 2018
Shehu, Usman L.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 68 - 68
[6] Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus
Kew, O
Morris-Glasgow, V
Landaverde, M
Burns, C
Shaw, J
Garib, Z
André, J
Blackman, E
Freeman, CJ
Jorba, J
Sutter, R
Tambini, G
Venczel, L
Pedreira, C
Laender, F
Shimizu, H
Yoneyama, T
Miyamura, T
van der Avoort, H
Oberste, MS
Kilpatrick, D
Cochi, S
Pallansch, M
de Quadros, C
SCIENCE, 2002, 296 (5566) : 356 - 359
[7] Emergence of vaccine-derived poliovirus type 2 after using monovalent type 2 oral poliovirus vaccine in an outbreak response, Philippines
Alipon, Sweet C. B.
Takashima, Yoshihiro
Avagyan, Tigran
Grabovac, Varja
Aslam, Syeda Kanwal
Bayutas, Benjamin
Logronio, Josephine
Wang, Xiaojun
Shrestha, Achyut
Neupane, Sukadeo
Roces, Maria Concepcion
Apostol, Lea Necitas
Sucaldito, Nemia
WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2022, 13 (02)
[8] Update on Vaccine-Derived Poliovirus Outbreaks - Democratic Republic of the Congo and Horn of Africa, 2017-2018
Mbaeyi, Chukwuma
Alleman, Mary M.
Ehrhardt, Derek
Wiesen, Eric
Burns, Cara C.
Liu, Hongmei
Ewetola, Raimi
Seakamela, Lerato
Mdodo, Rennatus
Ndoutabe, Modjirom
Wenye, Pierre Kandolo
Riziki, Yogolelo
Borus, Peter
Kamugisha, Christopher
Wassilak, Steven G. F.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (09): : 225 - 230
[9] Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019
Odoom, John Kofi
Dzotse, Emmanuel Kofi
Nii-Trebi, Nicholas Israel
Opare, David
Akyereko, Ernest
Attiku, Keren
Duker, Ewurabena Oduma
Eshun, Miriam
Boahene, Bismarck Banahene
Gberbi, Emmanuel
Houphouet, Ekua Essumanma
Diamenu, Stanley
Adjabeng, Michael
Asamoah-Frimpong, Joseph
Ameme, Donne
Opare, Joseph Kojo Larbi
Obodai, Evangeline
BIOMED RESEARCH INTERNATIONAL, 2024, 2024
[10] Outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Indonesia in 2023-2024
Ashique, Sumel
Srivastava, Shriyansh
Sridhar, Sathvik Belagodu
Kumar, Sachin
Rahaman, Abdul S. K.
Hussain, Md Sadique
Mohanty, Aroop
Sah, Sanjit
Mehta, Rachana
EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):

← 1 2 3 4 5 →